M&A Deal Summary |
|
|---|---|
| Date | 2008-11-25 |
| Target | Teva Pharmaceutical Industries - Portfolio Of Generic Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Watson Pharmaceuticals |
| Sellers(s) | Teva Pharmaceutical Industries |
| Deal Type | Divestiture |
| Deal Value | 36M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1931 |
| Sector | Medical Products |
| Employees | 1,325 |
Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 9 |
| Sector (Life Science) | 4 of 5 |
| Type (Divestiture) | 2 of 3 |
| Country (Israel) | 1 of 1 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 5 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-04-13 |
Sekhsaria Chemicals
Mumbai,, India Sekhsaria provides process research and development and contract manufacturing services to the global pharmaceutical industry, including the development and manufacture of active pharmaceutical ingredients (API) and related intermediates. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-02 |
Watson Pharmaceuticals - Abbreviated New Drug Application
United States Watson Pharmaceuticals - Abbreviated New Drug Application is for Cabergoline, the generic equivalent to Dostinex®. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 35,001 |
| Revenue | 15.8B USD (2023) |
Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 9 |
| Sector (Life Science) | 1 of 8 |
| Type (Divestiture) | 1 of 8 |
| Country (Israel) | 1 of 4 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-03-31 |
Bentley Pharmaceuticals
Exeter, New Hampshire, United States Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley's proprietary drug delivery technologies enhance the absorption of pharmaceutical compounds across various membranes. Bentley manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases through its subsidiaries -- Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentley also manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API. |
Buy | $360M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-23 |
Barr Pharmaceuticals
Montvale, New Jersey, United States Barr Pharmaceuticals, Inc. manufactures generic and proprietary pharmaceuticals in US. |
Buy | $7.5B |
